FONT-SIZE Plus   Neg

Lorus Therapeutics Q3 Loss Narrows - Quick Facts

Canadian biopharmaceutical company Lorus Therapeutics Inc. (LOR.TO,LRUSF.PK) posted a narrower loss in the third quarter.

The company posted third-quarter net loss of C$1.0 million or C$0.05per share, narrower than than C$1.5 million or C$0.10 per share last year. Lorus Therapeutics attributed the wider net loss mainly to higher general and administrative, and research and development expenditures.

The company did not generate any revenues in both the quarters.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
Follow RTT